Workflow
Charles Schwab Corporation
icon
Search documents
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Golden Entertainment, Inc (Nasdaq - GDEN), Brighthouse Financial, Inc. (Nasdaq - BHF), Forge Global Holdings, Inc. (NYSE - FRGE), Hologic, Inc. (Nasdaq – HOLX)
Globenewswire· 2025-11-06 18:54
Merger Agreements and Investigations - Golden Entertainment will be acquired by Blake L. Sartini and VICI Properties in a sale-leaseback transaction, with stockholders receiving $30.00 per share, consisting of 0.902 shares of VICI common stock and $2.75 in cash [2] - Brighthouse Financial will be acquired by an affiliate of Aquarian Capital for $70.00 per share in an all-cash transaction valued at approximately $4.1 billion [4] - Forge Global Holdings will be acquired by Charles Schwab Corporation for $45 cash per common share [6] - Hologic will be acquired by Blackstone for $76 per share in cash, plus a contingent value right potentially worth up to $3 per share, totaling up to $79 per share [8] Investigations on Fiduciary Duties - Investigations are ongoing regarding whether the boards of Golden Entertainment, Brighthouse Financial, Forge Global Holdings, and Hologic breached their fiduciary duties by failing to conduct a fair process and whether the deal considerations provide fair value to shareholders [2][4][6][8]
These Analysts Boost Their Forecasts On Charles Schwab Following Better-Than-Expected Q3 Results
Benzinga· 2025-10-17 13:31
Core Insights - Charles Schwab Corporation reported third-quarter adjusted earnings per share of $1.31, a 70% year-over-year increase, surpassing the analyst consensus estimate of $1.25 [1] - Quarterly sales reached $6.135 billion, reflecting a 27% year-over-year growth, exceeding the expected $6.009 billion [1] Financial Performance - The company experienced record revenue and earnings per share driven by strengthening organic growth trends and increasing adoption of wealth solutions [2] - Client transactional sweep cash increased by $13.5 billion compared to the second quarter, which contributed to a reduction in higher-cost bank funding by $12.9 billion, bringing it down to $14.8 billion at quarter-end [2] Analyst Ratings and Price Targets - Deutsche Bank analyst Brian Bedell maintained a Buy rating on Charles Schwab and raised the price target from $119 to $120 [5] - Keefe, Bruyette & Woods analyst Kyle Voigt also maintained an Outperform rating and increased the price target from $109 to $111 [5]
Dow Surges Over 100 Points; Charles Schwab Posts Upbeat Earnings - Hyperfine (NASDAQ:HYPR), Mira Pharmaceuticals (NASDAQ:MIRA)
Benzinga· 2025-10-16 14:00
Market Overview - U.S. stocks experienced an upward trend, with the Dow Jones index increasing by over 100 points, closing at 46,412.27, a rise of 0.34% [1] - The NASDAQ rose by 0.73% to 22,834.55, and the S&P 500 gained 0.41% to 6,698.54 [1] - Communication services sector saw a notable increase of 1.4%, while financial stocks declined by 0.7% [1] Company Earnings - Charles Schwab Corporation reported third-quarter adjusted earnings per share of $1.31, reflecting a 70% year-over-year increase, surpassing the analyst consensus estimate of $1.25 [2] - The company's quarterly sales reached $6.135 billion, a 27% year-over-year growth, exceeding the expected $6.009 billion [2] Commodity Market - Oil prices increased by 0.2% to $58.38, while gold rose by 1.6% to $4,269.40 [5] - Silver saw a 2.1% increase to $52.455, whereas copper fell by 1% to $4.9660 [5] Asian Market Performance - Asian markets closed predominantly higher, with Japan's Nikkei 225 surging by 1.27% and India's BSE Sensex rising by 1.04% [7] - Hong Kong's Hang Seng index experienced a slight decline of 0.09%, while China's Shanghai Composite rose by 0.10% [7] Stock Movements - Praxis Precision Medicines Inc shares surged by 202% to $173.05 following positive Phase 3 trial results [9] - Vivakor Inc shares increased by 82% to $0.54 after announcing a $40 million credit facility [9] - Mira Pharmaceuticals Inc shares rose by 63% to $2.15 due to new preclinical data [9] - UTime Ltd shares plummeted by 83% to $0.20 after a $25 million registered direct offering announcement [9] - Theriva Biologics Inc shares fell by 49% to $0.43 after a $4 million warrant inducement agreement [9] - Hyperfine Inc shares decreased by 41% to $1.30 following a $17.5 million public offering announcement [9] Economic Indicators - The Philadelphia Fed Manufacturing Index dropped to a six-month low of -12.8 in October, down from 23.2 in the previous month, missing market estimates of 10 [10]
Dow Surges Over 100 Points; Charles Schwab Posts Upbeat Earnings
Benzinga· 2025-10-16 14:00
Market Overview - U.S. stocks traded higher, with the Dow Jones index gaining over 100 points, up 0.34% to 46,412.27, NASDAQ climbing 0.73% to 22,834.55, and S&P 500 rising 0.41% to 6,698.54 [1] - Communication services shares increased by 1.4%, while financial stocks fell by 0.7% [1] Company Earnings - Charles Schwab Corporation reported third-quarter adjusted earnings per share of $1.31, a 70% year-over-year increase, surpassing the analyst consensus estimate of $1.25 [2] - Quarterly sales reached $6.135 billion, reflecting a 27% year-over-year growth, exceeding the expected $6.009 billion [2] Commodity Market - Oil prices rose by 0.2% to $58.38, gold increased by 1.6% to $4,269.40, silver was up 2.1% to $52.455, while copper fell by 1% to $4.9660 [5] Asian Market Performance - Asian markets closed mostly higher, with Japan's Nikkei 225 surging 1.27%, China's Shanghai Composite rising 0.10%, and India's BSE Sensex increasing by 1.04% [7] Stock Movements - Praxis Precision Medicines Inc shares surged 202% to $173.05 following positive Phase 3 trial results [9] - Vivakor Inc shares rose 82% to $0.54 after announcing a $40 million credit facility [9] - Mira Pharmaceuticals Inc shares increased by 63% to $2.15 due to new preclinical data [9] - UTime Ltd shares dropped 83% to $0.20 after a $25 million registered direct offering [9] - Theriva Biologics Inc shares fell 49% to $0.43 after a $4 million warrant inducement agreement [9] - Hyperfine Inc shares decreased by 41% to $1.30 following a $17.5 million public offering [9] Economic Indicators - The Philadelphia Fed Manufacturing Index declined to -12.8 in October from 23.2 in the previous month, missing market estimates of 10 [10]